Sphinx Trading’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Sphinx Trading’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$10K	Hold	111	–	–	0.02%	89
2016 Q3	$15K	Sell	111 -222	-67%	-$22K	0.03%	85
2016 Q2	$34K	Sell	333 -300	-47%	-$37.2K	0.07%	87
2016 Q1	$104K	Sell	633 -145	-19%	-$29.4K	0.19%	51
2015 Q4	$255K	Buy	778 +145	+23%	+$47.2K	0.35%	34
2015 Q3	$204K	Sell	633 -34	-5%	-$14.9K	0.21%	48
2015 Q2	$266K	Sell	667 -277	-29%	-$118K	0.3%	36
2015 Q1	$465K	Buy	944 +611	+183%	+$237K	0.65%	23
2014 Q4	$120K	Buy	+333	New	+$99.1K	0.1%	57

Other funds holding LUMO

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Sphinx Trading's LUMO Position: Q4 2021 in Review

Sphinx Trading held its Lumos Pharma, Inc. Common Stock (LUMO) position steady in Q4 2021 at 277 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #141.

Sphinx Trading first reported a position in LUMO in Q1 2015 and has held it in 7 quarters since. The position peaked at $56K in Q2 2016. 38 funds tracked by Wall St. Rank hold LUMO as of Q4 2021.

Sphinx Trading held 277 shares of Lumos Pharma, Inc. Common Stock worth $2K as of Q4 2021.
Sphinx Trading left its Lumos Pharma, Inc. Common Stock share count unchanged in Q4 2021.
Lumos Pharma, Inc. Common Stock made up ﹤0.01% of Sphinx Trading's portfolio in Q4 2021, its #141 holding.
Sphinx Trading first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2015 and has held it in 7 quarters since.
Sphinx Trading's Lumos Pharma, Inc. Common Stock position peaked at $56K in Q2 2016.
38 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2021.

Based on Sphinx Trading's 13F filing for Q4 2021, filed 31 Jan 2022.